東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Novel biomarkers in the continuum of...

Stearns, Vered.

Linked to FindBook

Google Book

Amazon

博客來

Novel biomarkers in the continuum of breast cancer

Record Type:	Electronic resources : Monograph/item
Title/Author:	Novel biomarkers in the continuum of breast cancer/ edited by Vered Stearns.
other author:	Stearns, Vered.
Published:	Cham :Springer International Publishing : : 2016.,
Description:	xix, 279 p. :ill. (some col.), digital ;24 cm.
[NT 15003449]:	1 Genomic Biomarkers for Cancer Risk -- 2 Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum -- 3 Incorporating Biomarkers in Studies of Chemoprevention -- 4 Breast Molecular Profiling and Radiotherapy Considerations -- 5 Prognostic and Predictive Biomarkers of Endocrine Responsiveness For Estrogen Receptor Positive Breast Cancer -- 6 Biomarkers for predicting response to Anti-HER2 Agents -- 7 Intratumor Heterogeneity in Breast Cancer -- 8 Intratumor Heterogeneity in Breast Cancer -- 9 Pharmacogenetic Predictors of Response -- 10 Metabolomics in Breast Cancer: Current Status and Perspectives -- 11 Circulating Tumor Cells -- 12 Circulating Plasma Tumor DNA.
Contained By:	Springer eBooks
Subject:	Tumor markers. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-22909-6
ISBN:	9783319229096

Novel biomarkers in the continuum of breast cancer
Novel biomarkers in the continuum of breast cancer[electronic resource] /edited by Vered Stearns. - Cham :Springer International Publishing :2016. - xix, 279 p. :ill. (some col.), digital ;24 cm. - Advances in experimental medicine and biology,v.8820065-2598 ;. - Advances in experimental medicine and biology ;946..

1 Genomic Biomarkers for Cancer Risk -- 2 Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum -- 3 Incorporating Biomarkers in Studies of Chemoprevention -- 4 Breast Molecular Profiling and Radiotherapy Considerations -- 5 Prognostic and Predictive Biomarkers of Endocrine Responsiveness For Estrogen Receptor Positive Breast Cancer -- 6 Biomarkers for predicting response to Anti-HER2 Agents -- 7 Intratumor Heterogeneity in Breast Cancer -- 8 Intratumor Heterogeneity in Breast Cancer -- 9 Pharmacogenetic Predictors of Response -- 10 Metabolomics in Breast Cancer: Current Status and Perspectives -- 11 Circulating Tumor Cells -- 12 Circulating Plasma Tumor DNA.

This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to today's standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research. Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment for individual patients.

ISBN: 9783319229096

Standard No.: 10.1007/978-3-319-22909-6doiSubjects--Topical Terms:

775321
Tumor markers.

LC Class. No.: RC270.3.T84

Dewey Class. No.: 616.99449075

Novel biomarkers in the continuum of breast cancer
LDR:02649nmm m2200325 m 4500 001 2032376
003 DE-He213
005 20160908155904.0
006 m d
007 cr nn 008maaau
008 161011s2016 gw s 0 eng d
020 $a 9783319229096 $q (electronic bk.)
020 $a 9783319229089 $q (paper)
024 7 $a 10.1007/978-3-319-22909-6 $2 doi
035 $a 978-3-319-22909-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.3.T84
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99449075 $2 23
090 $a RC270.3.T84 $b N937 2016
245 0 0 $a Novel biomarkers in the continuum of breast cancer $h [electronic resource] / $c edited by Vered Stearns.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xix, 279 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.882
505 0 $a 1 Genomic Biomarkers for Cancer Risk -- 2 Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum -- 3 Incorporating Biomarkers in Studies of Chemoprevention -- 4 Breast Molecular Profiling and Radiotherapy Considerations -- 5 Prognostic and Predictive Biomarkers of Endocrine Responsiveness For Estrogen Receptor Positive Breast Cancer -- 6 Biomarkers for predicting response to Anti-HER2 Agents -- 7 Intratumor Heterogeneity in Breast Cancer -- 8 Intratumor Heterogeneity in Breast Cancer -- 9 Pharmacogenetic Predictors of Response -- 10 Metabolomics in Breast Cancer: Current Status and Perspectives -- 11 Circulating Tumor Cells -- 12 Circulating Plasma Tumor DNA.
520 $a This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to today's standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research. Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment for individual patients.
650 0 $a Tumor markers. $3 775321
650 0 $a Breast $x Cancer $x Diagnosis. $3 815865
650 0 $a Breast $x Cancer $x Molecular aspects. $3 2160346
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Cancer Research. $3 891172
650 2 4 $a Oncology. $3 751006
650 2 4 $a Human Genetics. $3 891169
700 1 $a Stearns, Vered. $3 2186356
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 1565434
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-22909-6
950 $a Biomedical and Life Sciences (Springer-11642)